Elderly women above screening age diagnosed with cervical cancer have a worse prognosis
- PMID: 25202106
Elderly women above screening age diagnosed with cervical cancer have a worse prognosis
Abstract
Aim: To analyze the cervical screening history in women with cervical cancer and their outcome.
Design: All women diagnosed with cervical cancer between January 2009 and December 2010 in the South Sweden region were included in the audit.
Materials and methods: Cervical cancer was registered in 165 women in 2009 and 2010. Their screening history was analyzed, and was classified as normal or imperfect. The method of discovering the cancer was either by symptoms or by screening. The main outcome measured was overall survival in cervical cancer related to cervical screening history.
Results: Women above 65 years of age were more frequently diagnosed with advanced-stage disease (The International Federation of Gynecology and Obstetrics II-IV) (n=36 out of 43; 84%) compared to women below 65 years of age (n=35 out of 122; 29%) (p<0.001). All patients diagnosed by the cervical screening program were still alive (30/30) at the median follow-up time (36 months), showing better overall survival compared to women below screening age in whom cancer was discovered due to symptoms (68/98; p<0.001). Cox proportional hazards model showed that women beyond screening age (>65 years old) with normal screening history had a worse prognosis, with a hazard ratio of 4.8 (95% confidence interval=1.9-12.1, p=0.001), and women (>65 years old) who had not followed the screening program had a hazard ratio of 5.9 (95% confidence interval I 2.4-14.6, p<0.001), compared to women under 65 years old who had followed the screening program.
Conclusion: Cervical cancer in women above the age of 65 years is discovered at advanced stages of the disease and their prognosis is poor.
Keywords: Cervical screening program; HPV test; Swedish population; cervical cancer; overall survival.
Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.
Similar articles
-
Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.J Natl Cancer Inst. 2008 May 7;100(9):622-9. doi: 10.1093/jnci/djn099. Epub 2008 Apr 29. J Natl Cancer Inst. 2008. PMID: 18445828
-
Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.Eur J Obstet Gynecol Reprod Biol. 2008 Aug;139(2):204-9. doi: 10.1016/j.ejogrb.2007.10.017. Epub 2008 Feb 21. Eur J Obstet Gynecol Reprod Biol. 2008. PMID: 18093720
-
Screening patterns within organized programs and survival of Italian women with invasive cervical cancer.Prev Med. 2013 Sep;57(3):220-6. doi: 10.1016/j.ypmed.2013.05.018. Epub 2013 Jun 1. Prev Med. 2013. PMID: 23732239
-
[Characteristics of uterine cancer detected by mass screening].Gan To Kagaku Ryoho. 1998 Aug;25(10):1519-26. Gan To Kagaku Ryoho. 1998. PMID: 9725043 Review. Japanese.
-
Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.Cancer. 2003 May 1;97(9):2196-202. doi: 10.1002/cncr.11371. Cancer. 2003. PMID: 12712471 Review.
Cited by
-
HPV prevalence and HPV-related dysplasia in elderly women.PLoS One. 2018 Jan 10;13(1):e0189300. doi: 10.1371/journal.pone.0189300. eCollection 2018. PLoS One. 2018. PMID: 29320507 Free PMC article.
-
Incidence of HPV and HPV related dysplasia in elderly women in Sweden.PLoS One. 2020 Mar 20;15(3):e0229758. doi: 10.1371/journal.pone.0229758. eCollection 2020. PLoS One. 2020. PMID: 32196503 Free PMC article.
-
History of HPV in HPV-positive elderly women.Eur J Obstet Gynecol Reprod Biol X. 2024 Mar 7;22:100297. doi: 10.1016/j.eurox.2024.100297. eCollection 2024 Jun. Eur J Obstet Gynecol Reprod Biol X. 2024. PMID: 38496379 Free PMC article.
-
Cervical intraepithelial neoplasia in women with transformation zone type 3: cervical biopsy versus large loop excision.BJOG. 2022 Dec;129(13):2132-2140. doi: 10.1111/1471-0528.17200. Epub 2022 May 26. BJOG. 2022. PMID: 35488417 Free PMC article.
-
Age-specific and genotype-specific carcinogenic human papillomavirus prevalence in a country with a high cervical cancer burden: results of a cross-sectional study in Estonia.BMJ Open. 2023 Jun 1;13(6):e069558. doi: 10.1136/bmjopen-2022-069558. BMJ Open. 2023. PMID: 37263686 Free PMC article.